InspireMD, Inc. (NSPR)
USD 2.53
(-5.87%)
USD 2.53
(-5.87%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.1 Million USD | 29.92% |
| 2022 | 1.62 Million USD | 41.82% |
| 2021 | 1.14 Million USD | -19.22% |
| 2020 | 1.41 Million USD | 14.48% |
| 2019 | 1.23 Million USD | 8.99% |
| 2018 | 1.13 Million USD | 112.76% |
| 2017 | 533 Thousand USD | 6.6% |
| 2016 | 500 Thousand USD | -33.6% |
| 2015 | 753 Thousand USD | -60.86% |
| 2014 | 1.92 Million USD | 20.78% |
| 2013 | 1.59 Million USD | -11.84% |
| 2012 | 1.8 Million USD | -16.77% |
| 2011 | 2.17 Million USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 2.2 Million USD | -6.53% |
| 2024 Q1 | 2.36 Million USD | 12.06% |
| 2023 Q3 | 1.84 Million USD | 9.3% |
| 2023 FY | 2.1 Million USD | 29.92% |
| 2023 Q1 | 1.69 Million USD | 4.69% |
| 2023 Q2 | 1.68 Million USD | -0.47% |
| 2023 Q4 | 2.1 Million USD | 14.08% |
| 2022 Q2 | 1.45 Million USD | 13.06% |
| 2022 Q3 | 1.41 Million USD | -2.75% |
| 2022 Q4 | 1.62 Million USD | 14.64% |
| 2022 Q1 | 1.28 Million USD | 12.51% |
| 2022 FY | 1.62 Million USD | 41.82% |
| 2021 Q4 | 1.14 Million USD | 0.7% |
| 2021 FY | 1.14 Million USD | -19.22% |
| 2021 Q3 | 1.13 Million USD | -15.42% |
| 2021 Q2 | 1.34 Million USD | 13.34% |
| 2021 Q1 | 1.18 Million USD | -16.33% |
| 2020 Q1 | 1.2 Million USD | -2.75% |
| 2020 Q2 | 1.4 Million USD | 16.64% |
| 2020 FY | 1.41 Million USD | 14.48% |
| 2020 Q3 | 1.38 Million USD | -1.0% |
| 2020 Q4 | 1.41 Million USD | 1.95% |
| 2019 Q3 | 1.28 Million USD | 5.34% |
| 2019 Q4 | 1.23 Million USD | -3.66% |
| 2019 FY | 1.23 Million USD | 8.99% |
| 2019 Q1 | 1.44 Million USD | 27.6% |
| 2019 Q2 | 1.21 Million USD | -15.83% |
| 2018 Q4 | 1.13 Million USD | 38.97% |
| 2018 Q3 | 816 Thousand USD | 28.1% |
| 2018 FY | 1.13 Million USD | 112.76% |
| 2018 Q1 | 517 Thousand USD | -3.0% |
| 2018 Q2 | 637 Thousand USD | 23.21% |
| 2017 Q2 | 429 Thousand USD | 30.4% |
| 2017 Q1 | 329 Thousand USD | -34.2% |
| 2017 Q3 | 576 Thousand USD | 34.27% |
| 2017 Q4 | 533 Thousand USD | -7.47% |
| 2017 FY | 533 Thousand USD | 6.6% |
| 2016 Q1 | 511 Thousand USD | -32.14% |
| 2016 FY | 500 Thousand USD | -33.6% |
| 2016 Q4 | 500 Thousand USD | 36.99% |
| 2016 Q2 | 387 Thousand USD | -24.27% |
| 2016 Q3 | 365 Thousand USD | -5.68% |
| 2015 Q1 | 1.75 Million USD | -9.04% |
| 2015 Q4 | 753 Thousand USD | -30.34% |
| 2015 Q3 | 1.08 Million USD | -12.04% |
| 2015 Q2 | 1.22 Million USD | -29.77% |
| 2015 FY | 753 Thousand USD | -60.86% |
| 2014 Q2 | 1.51 Million USD | 12.73% |
| 2014 FY | 1.92 Million USD | 20.78% |
| 2014 Q1 | 1.34 Million USD | 0.0% |
| 2014 Q4 | 1.92 Million USD | 14.39% |
| 2014 Q3 | 1.68 Million USD | 11.1% |
| 2013 FY | 1.59 Million USD | -11.84% |
| 2013 Q2 | 1.59 Million USD | -19.63% |
| 2013 Q3 | 1.39 Million USD | -12.62% |
| 2013 Q1 | 1.98 Million USD | -0.75% |
| 2012 Q4 | 1.99 Million USD | -4.81% |
| 2012 Q3 | 2.09 Million USD | 16.1% |
| 2012 FY | 1.8 Million USD | -16.77% |
| 2012 Q1 | 2.07 Million USD | -4.38% |
| 2012 Q2 | 1.8 Million USD | -12.96% |
| 2011 Q1 | 1.66 Million USD | 0.0% |
| 2011 FY | 2.17 Million USD | 0.0% |
| 2011 Q2 | 1.55 Million USD | -6.61% |
| 2011 Q3 | 2 Million USD | 29.23% |
| 2011 Q4 | 2.17 Million USD | 8.17% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | 36.375% |
| BrainsWay Ltd. | 3.71 Million USD | 43.341% |
| Cerus Corporation | 39.86 Million USD | 94.718% |
| Envoy Medical, Inc. | 1.4 Million USD | -50.0% |
| electroCore, Inc. | 2.16 Million USD | 2.5% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -360.832% |
| IceCure Medical Ltd | 2.27 Million USD | 7.429% |
| Inogen, Inc. | 21.84 Million USD | 90.357% |
| OrthoPediatrics Corp. | 105.85 Million USD | 98.01% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -657.554% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -210599900.0% |
| MaxCyte, Inc. | 12.22 Million USD | 82.779% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -21.968% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -1246.375% |
| Orthofix Medical Inc. | 222.16 Million USD | 99.052% |
| PAVmed Inc | 1.01 Million USD | -107.08% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 89.449% |
| RxSight, Inc. | 17.42 Million USD | 87.911% |
| Sight Sciences, Inc. | 7.84 Million USD | 73.169% |
| SI-BONE, Inc. | 20.24 Million USD | 89.599% |
| TELA Bio, Inc. | 13.16 Million USD | 83.999% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 92.799% |
| Vivos Therapeutics, Inc. | 1.00 USD | -210599900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | 50.771% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -815.652% |
| Nano-X Imaging Ltd. | 2.35 Million USD | 10.611% |
| CVRx, Inc. | 10.98 Million USD | 80.825% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -439.895% |
| Bioventus Inc. | 91.33 Million USD | 97.694% |
| Venus Concept Inc. | 28.67 Million USD | 92.656% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | 17.25% |
| LivaNova PLC | 147.88 Million USD | 98.576% |
| 908 Devices Inc. | 14.93 Million USD | 85.902% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 98.461% |
| Nemaura Medical Inc. | 1.75 Million USD | -20.01% |
| NeuroPace, Inc. | 11.21 Million USD | 81.22% |
| LENSAR, Inc. | 15.68 Million USD | 86.577% |
| Apyx Medical Corporation | 9.92 Million USD | 78.777% |
| Cutera, Inc. | 72.1 Million USD | 97.079% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | 21.212% |
| BioSig Technologies, Inc. | -103 Thousand USD | 2144.66% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 95.46% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | 73.379% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 99.459% |
| Axonics, Inc. | 79.94 Million USD | 97.366% |
| Outset Medical, Inc. | 49.21 Million USD | 95.721% |
| IRIDEX Corporation | 9.9 Million USD | 78.74% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 94.703% |
| IRadimed Corporation | 12.82 Million USD | 83.574% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -178.571% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -696.198% |
| Telesis Bio, Inc. | 4.02 Million USD | 47.677% |
| Viemed Healthcare, Inc. | 4.6 Million USD | 54.26% |
| Varex Imaging Corporation | 277.5 Million USD | 99.241% |
| Quipt Home Medical Corp. | 18.32 Million USD | 88.508% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | 87.422% |
| Dynatronics Corporation | 5.59 Million USD | 62.352% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | 43.705% |
| Semler Scientific, Inc. | 445 Thousand USD | -373.258% |
| InMode Ltd. | 45.09 Million USD | 95.33% |
| Bruker Corporation | 968.3 Million USD | 99.783% |
| Cytosorbents Corporation | 3.68 Million USD | 42.774% |
| DexCom, Inc. | 559.6 Million USD | 99.624% |
| Align Technology, Inc. | 296.9 Million USD | 99.291% |
| Viveve Medical, Inc. | 1.47 Million USD | -43.071% |
| ZimVie Inc. | 79.6 Million USD | 97.354% |
| Movano Inc. | 1.51 Million USD | -39.194% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 96.541% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -1246.375% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 98.667% |
| Profound Medical Corp. | 6.95 Million USD | 69.712% |
| Insulet Corporation | 402.6 Million USD | 99.477% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | 85.808% |
| iCAD, Inc. | 917 Thousand USD | -129.662% |
| Nuwellis, Inc. | 1.99 Million USD | -5.458% |
| Biotricity, Inc. | 1.87 Million USD | -12.057% |
| iRhythm Technologies, Inc. | 13.97 Million USD | 84.928% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| PAVmed Inc. | 1.01 Million USD | -107.08% |
| BIOLASE, Inc. | 11.43 Million USD | 81.58% |
| Beyond Air, Inc. | 2.12 Million USD | 0.987% |
| FONAR Corporation | 2.71 Million USD | 22.444% |
| AxoGen, Inc. | 23.02 Million USD | 90.851% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 90.651% |
| Inari Medical, Inc. | 42.9 Million USD | 95.091% |
| UFP Technologies, Inc. | 70.19 Million USD | 97.0% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -234.722% |
| Tenon Medical, Inc. | 554 Thousand USD | -280.144% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -26.507% |
| AdaptHealth Corp. | 113.64 Million USD | 98.147% |
| Sintx Technologies, Inc. | 888 Thousand USD | -137.162% |
| NanoVibronix, Inc. | 2.73 Million USD | 22.914% |
| Quanterix Corporation | 22.36 Million USD | 90.584% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | 85.815% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 96.284% |
| TransMedics Group, Inc. | 44.23 Million USD | 95.239% |
| ReWalk Robotics Ltd. | 5.65 Million USD | 62.745% |
| NeuroMetrix, Inc. | 1.55 Million USD | -35.05% |
| Hyperfine, Inc. | 6.58 Million USD | 68.004% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 97.365% |
| Biomerica, Inc. | 2.37 Million USD | 11.364% |
| Bone Biologics Corporation | -328.84 Thousand USD | 740.425% |
| AVITA Medical, Inc. | 3.12 Million USD | 32.531% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 92.951% |